RASR Laboratories uses state-of-the art proteomics and mass spectrometry technology to further our understanding of aging and age-related diseases.
We are particularly interested in Alzheimer’s disease and sepsis and how the periphery is involved in these disorders. Recently, we have become interested in using our technology to understand the molecular basis of health disparities in Alzheimer’s disease and sepsis. These questions require high-throughput analytical methodology and we specialize in developing novel proteomics approaches involving mass spectrometry that are useful for analyzing complex biological tissues, increasing sample multiplexing capability, and studying oxidative post-translational modifications.
Our research includes
We have several active collaborations at the University and at other national institutions. If you are interested in potentially working with us feel free to contact us.